PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review

PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review

The advent of immune checkpoint inhibitors gave rise to a new era in oncology and general medicine. The increasing use of programmed death-1 (PD-1) inhibitors in non-small cell lung cancer and in other malignancies means clinicians have to face up to new challenges in managing immune-related adverse...

Full description

Bibliographic Details
Main Authors: Aurora Mirabile, Elena Brioschi, Monika Ducceschi, Sheila Piva, Chiara Lazzari, Alessandra Bulotta, Maria Grazia Viganò, Giovanna Petrella, Luca Gianni, Vanesa Gregorc
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:Cancers
Subjects:
immunotherapy
neurotoxicity
polyneuropathy
myasthenia gravis
Bell’s palsy
encephalopathy
nivolumab
pembrolizumab
Online Access:http://www.mdpi.com/2072-6694/11/3/296

Internet

http://www.mdpi.com/2072-6694/11/3/296

Similar Items